Patents-Review.com
🔗 Permalink
Assignee profile:

PFIZER INC.

City:

Groton, Connecticut

Country:

United States

Published Applications:

44

Last publication date:

2014-08-14

Patent Grants:

31

Last grant date:

2014-10-21

Top Inventors for applications by PFIZER INC.

These are the the leading inventors for applications assigned to PFIZER INC.:

Recent patent applications by PFIZER INC.

PFIZER INC. based in Groton, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-08-14 ✅ Patent 8,865,706 granted on 2014-10-21
US20140228356A1
Chemistry; metallurgy

Heteroaryl-substituted hexahydropyrano[3,4-][1,3]thiazin-2-amine compounds

 #2 | 2014-07-24 ✅ Patent 9,340,493 granted on 2016-05-17
US20140206651A1
Chemistry; metallurgy

Hydroxamic acid derivatives useful as antibacterial agents

 #3 | 2014-07-03 ✅ Patent 9,079,877 granted on 2015-07-14
US20140187794A1
Chemistry; metallurgy

Process for preparing chiral compounds

 #4 | 2014-05-22
US20140142316A1
Chemistry; metallurgy

Tricyclic Compounds, Compositions, And Methods

 #5 | 2014-03-27 ✅ Patent 8,916,564 granted on 2014-12-23
US20140088111A1
Chemistry; metallurgy

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

 #6 | 2014-03-27
US20140088081A1
Chemistry; metallurgy

Amino-Heterocyclic Compounds

 #7 | 2014-03-06 ✅ Patent 9,200,000 granted on 2015-12-01
US20140066622A1
Chemistry; metallurgy

Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders

 #8 | 2014-02-27 ✅ Patent 8,779,148 granted on 2014-07-15
US20140057919A1
Chemistry; metallurgy

Fluoro-pyridinone derivatives useful as antibacterial agents

 #9 | 2014-02-13 ✅ Patent 9,067,934 granted on 2015-06-30
US20140045790A1
Chemistry; metallurgy

Bicyclic pyridinones

 #10 | 2013-11-07 ✅ Patent 8,962,616 granted on 2015-02-24
US20130296308A1
Chemistry; metallurgy

Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

 #11 | 2013-09-26
US20130252935A1
Chemistry; metallurgy

Monobactams

 #12 | 2013-08-08
US20130203767A1
Human necessities

Treatment of Pulmonary Hypertension

 #13 | 2013-07-18
US20130184294A1
Chemistry; metallurgy

Pyrimidones for Treatment of Potassium Channel Related Diseases

 #14 | 2013-06-13 ✅ Patent 8,883,812 granted on 2014-11-11
US20130150391A1
Human necessities

Piperidinyl pyrimidine amides as Kv7 potassium channel openers

 #15 | 2013-06-13
US20130150376A1
Chemistry; metallurgy

Novel Sultam Compounds

 #16 | 2013-05-16
US20130121923A1
Human necessities

Treatment of Male Sexual Dysfunction

 #17 | 2013-01-31
US20130029377A1
Chemistry; metallurgy

RECOMBINANT APOA-1M FROM ENGINEERED BACTERIA

 #18 | 2012-10-25 ✅ Patent 8,802,688 granted on 2014-08-12
US20120270893A1
Chemistry; metallurgy

Substituted acetyl-coa carboxylase inhibitors

 #19 | 2012-09-06 ✅ Patent 8,389,552 granted on 2013-03-05
US20120225910A1
Chemistry; metallurgy

(S)-6-(2-(4-(cyclobutylsulfonyl)-1H-imidazol-1-yl)-3-cyclopentylpropanamido)nicotinic acid useful as a glucokinase activator

 #20 | 2012-08-23 ✅ Patent 8,796,287 granted on 2014-08-05
US20120214827A1
Chemistry; metallurgy

Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide

 #21 | 2012-08-16 ✅ Patent 8,796,288 granted on 2014-08-05
US20120208830A1
Chemistry; metallurgy

Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide

 #22 | 2011-09-15
US20110224231A1
Chemistry; metallurgy

Novel Lactams as Beta Secretase Inhibitors

 #23 | 2010-11-18
US20100292205A1
Chemistry; metallurgy

Pyrimidone Compounds As GSK-3 Inhibitors

 #24 | 2010-03-04 ✅ Patent 8,398,912 granted on 2013-03-19
US20100052221A1
Performing operations; transporting

Apparatus and method for removing molded articles from their molds

 #25 | 2008-10-30 ✅ Patent 7,994,120 granted on 2011-08-09
US20080269111A1
Human necessities

Method of treating dyslipidemic disorder

 #26 | 2008-10-07 ✅ Patent 7,432,370 granted on 2008-10-07
US10869101
-

Chiral salt resolution

 #27 | 2008-08-21
US20080199527A1
Human necessities

Enteric Coated Azithromycin Multiparticulates

 #28 | 2007-08-16
US20070191319A1
Human necessities

Treatment of conditions that present with low bone mass by continuous combination therapy with selective prostaglandin ep4 receptor agonists and an estrogen

 #29 | 2007-07-03 ✅ Patent 7,238,676 granted on 2007-07-03
US10869380
-

Purine derivatives

 #30 | 2007-06-28
US20070149567A1
Chemistry; metallurgy

Quinoline compounds

 #31 | 2007-06-19 ✅ Patent 7,232,823 granted on 2007-06-19
US10853993
-

Cannabinoid receptor ligands and uses thereof

 #32 | 2007-01-23 ✅ Patent 7,166,593 granted on 2007-01-23
US10721318
-

Glucocorticoid receptor modulators

 #33 | 2005-10-11 ✅ Patent 6,953,791 granted on 2005-10-11
US10371315
-

Dipeptide derivatives

 #34 | 2005-10-04 ✅ Patent 6,951,850 granted on 2005-10-04
US10371953
-

Dipeptide derivatives

 #35 | 2005-09-27 ✅ Patent 6,949,577 granted on 2005-09-27
US10390305
-

Pharmaceuticals

 #36 | 2005-08-02 ✅ Patent 6,924,280 granted on 2005-08-02
US10371330
-

Dipeptide derivatives

 #37 | 2005-06-16 ✅ Patent 7,232,816 granted on 2007-06-19
US20050130957A1
Chemistry; metallurgy

Substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medical products and processes for preparing them

 #38 | 2005-05-31 ✅ Patent 6,900,230 granted on 2005-05-31
US10189074
-

Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents

 #39 | 2005-03-31 ✅ Patent 7,030,338 granted on 2006-04-18
US20050067385A1
Performing operations; transporting

Pharmaceutical laser drilling system

 #40 | 2005-03-08 ✅ Patent 6,864,252 granted on 2005-03-08
US10286105
-

Hydrazinyl and nitrogen oxide pyrazoles

 #41 | 2005-02-10 ✅ Patent 7,112,599 granted on 2006-09-26
US20050032859A1
Chemistry; metallurgy

Oxazole compounds for the treatment of neurodegenerative disorders

 #42 | 2005-02-08 ✅ Patent 6,852,733 granted on 2005-02-08
US9836035
-

Sodium-hydrogen exchanger type 1 inhibitor

 #43 | 2005-01-25 ✅ Patent 6,847,840 granted on 2005-01-25
US9960546
-

System and method for statistical analysis of QT interval as a function of changes in RR interval

 #44 | 2005-01-04 ✅ Patent 6,838,458 granted on 2005-01-04
US10285746
-

5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles

Also check out Pfizer Inc.'s (Groton, United States) applicant profile with 13 patent applications submitted.

AssigneeID:

7226 ⎘